Skip to main content
Equibles

Rafferty Asset Management, LLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1389426 New York, NY
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$702,072
+$13,148 QoQ
Shares Held
337,535
+19.5% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 209 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. ALLO ranks #106 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 65,798 $32,683,840
2 REGN
Regeneron Pharmaceuticals, Inc.
 38,534 $24,027,490
3 ALNY
Alnylam Pharmaceuticals, Inc.
 55,332 $16,656,591
4 MRNA
Moderna, Inc.
 111,906 $7,836,777
5 INCY
Incyte Corp
 44,663 $5,062,997
6 APGE
Apogee Therapeutics, Inc.
 33,369 $4,429,067
7 TWST
Twist Bioscience Corp
 40,732 $4,190,508
8 ORKA
Oruka Therapeutics, Inc.
 43,110 $4,102,778

All Filings in ALLO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $702,072 337,535
2026-03-31 $688,924 282,346
2024-12-31 $782,657 367,445
2024-09-30 $887,448 316,946
2024-06-30 $1,362,677 584,840
2024-03-31 $4,428,442 990,703
2023-12-31 $735,115 229,008
2023-09-30 $2,866,957 904,403
2023-06-30 $4,396,317 884,571
2023-03-31 $3,344,562 677,037
2022-12-31 $4,758,435 756,508
2022-09-30 $4,966,174 459,831
2022-06-30 $2,529,192 221,859
2022-03-31 $5,173,732 567,918
2021-12-31 $4,407,054 295,379
2021-09-30 $3,373,921 131,281
2021-06-30 $2,606,513 99,943
2021-03-31 $3,056,379 86,583
2020-12-31 $858,109 33,998
2020-09-30 $2,310,755 61,277
2020-06-30 $978,394 22,849